Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature

Background: Anemia treatment in infants with advanced or chronic kidney disease (CKD) represents an important challenge to nephrologists. The use of darbepoetin alfa, a novel erythropoiesis stimulating agent, has largely replaced recombinant human erythropoietin in older children and in adults with...

Descripción completa

Detalles Bibliográficos
Autores principales: Libudzic-Nowak, Anna Maria, Cachat, Francois, Pascual, Manuel, Chehade, Hassib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305342/
https://www.ncbi.nlm.nih.gov/pubmed/30619793
http://dx.doi.org/10.3389/fped.2018.00398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305342/
https://www.ncbi.nlm.nih.gov/pubmed/30619793
http://dx.doi.org/10.3389/fped.2018.00398

Ejemplares similares